

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.09725680 |
| 2 | sarcomere organization (GO:0045214) | 5.59504552 |
| 3 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.40789365 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.28317793 |
| 5 | cardiac myofibril assembly (GO:0055003) | 5.07896406 |
| 6 | carnitine shuttle (GO:0006853) | 4.96070441 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 4.95798262 |
| 8 | plasma membrane repair (GO:0001778) | 4.93497998 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91686406 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.78865655 |
| 11 | cardiac muscle contraction (GO:0060048) | 4.69859711 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.66232479 |
| 13 | myofibril assembly (GO:0030239) | 4.60722479 |
| 14 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46537825 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.44351084 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.42990438 |
| 17 | fatty acid transmembrane transport (GO:1902001) | 4.42822451 |
| 18 | muscle filament sliding (GO:0030049) | 4.37600474 |
| 19 | actin-myosin filament sliding (GO:0033275) | 4.37600474 |
| 20 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.29263372 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.27212868 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 4.26519204 |
| 23 | modulation by symbiont of host defense response (GO:0052031) | 4.26519204 |
| 24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.26519204 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.26519204 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.26519204 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 4.26519204 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25953671 |
| 29 | negative regulation of cell killing (GO:0031342) | 4.23589103 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.23589103 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.21776849 |
| 32 | regulation of skeletal muscle contraction (GO:0014819) | 4.19838245 |
| 33 | response to peptidoglycan (GO:0032494) | 4.11031987 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 4.06444422 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.03691745 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98273436 |
| 37 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96395329 |
| 38 | striated muscle contraction (GO:0006941) | 3.92010014 |
| 39 | germinal center formation (GO:0002467) | 3.89270973 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.87914967 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86568689 |
| 42 | regulation of actin filament-based movement (GO:1903115) | 3.85777159 |
| 43 | carnitine transmembrane transport (GO:1902603) | 3.85407676 |
| 44 | regulation of relaxation of muscle (GO:1901077) | 3.81261673 |
| 45 | regulation of cell communication by electrical coupling (GO:0010649) | 3.80178619 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80013326 |
| 47 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.76039889 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74115411 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73435149 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 3.73384821 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.73384821 |
| 52 | cell communication by electrical coupling (GO:0010644) | 3.72862605 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72168241 |
| 54 | regulation of membrane repolarization (GO:0060306) | 3.70290184 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.69554862 |
| 56 | actomyosin structure organization (GO:0031032) | 3.69106634 |
| 57 | carnitine transport (GO:0015879) | 3.63027742 |
| 58 | amino-acid betaine transport (GO:0015838) | 3.63027742 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62603470 |
| 60 | cardiac muscle hypertrophy (GO:0003300) | 3.61755571 |
| 61 | actin-mediated cell contraction (GO:0070252) | 3.58383874 |
| 62 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.55405830 |
| 63 | cardiac muscle cell development (GO:0055013) | 3.53065481 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.52360767 |
| 65 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52307160 |
| 66 | NADH metabolic process (GO:0006734) | 3.51853473 |
| 67 | striated muscle hypertrophy (GO:0014897) | 3.47626808 |
| 68 | lysine catabolic process (GO:0006554) | 3.46174282 |
| 69 | lysine metabolic process (GO:0006553) | 3.46174282 |
| 70 | detection of other organism (GO:0098543) | 3.44420555 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41339460 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 3.40873973 |
| 73 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.32811422 |
| 74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.32811422 |
| 75 | regulation of necroptotic process (GO:0060544) | 3.31404082 |
| 76 | succinate metabolic process (GO:0006105) | 3.30260522 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 3.29833020 |
| 78 | cardiac cell development (GO:0055006) | 3.29373519 |
| 79 | potassium ion import (GO:0010107) | 3.28434836 |
| 80 | sodium ion export (GO:0071436) | 3.28262458 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27492703 |
| 82 | creatine metabolic process (GO:0006600) | 3.27383433 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 3.25824037 |
| 84 | cellular extravasation (GO:0045123) | 3.25425407 |
| 85 | detection of bacterium (GO:0016045) | 3.24895630 |
| 86 | oxaloacetate metabolic process (GO:0006107) | 3.24131689 |
| 87 | detection of molecule of bacterial origin (GO:0032490) | 3.24050325 |
| 88 | negative regulation of potassium ion transport (GO:0043267) | 3.21987430 |
| 89 | aspartate family amino acid catabolic process (GO:0009068) | 3.19401869 |
| 90 | relaxation of cardiac muscle (GO:0055119) | 3.18703151 |
| 91 | regulation of striated muscle contraction (GO:0006942) | 3.18177444 |
| 92 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.18176878 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 3.13747630 |
| 94 | regulation of fatty acid oxidation (GO:0046320) | 3.12138885 |
| 95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.11819676 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08572878 |
| 97 | regulation of the force of heart contraction (GO:0002026) | 3.07386876 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07255659 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07147079 |
| 100 | muscle hypertrophy (GO:0014896) | 3.06937451 |
| 101 | cardiac conduction (GO:0061337) | 3.06615127 |
| 102 | detection of external biotic stimulus (GO:0098581) | 3.05481239 |
| 103 | actin filament-based movement (GO:0030048) | 3.04898154 |
| 104 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.04069021 |
| 105 | regulation of synapse structural plasticity (GO:0051823) | 3.03281282 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00160061 |
| 107 | negative regulation of necroptotic process (GO:0060546) | 3.00090561 |
| 108 | regulation of sulfur metabolic process (GO:0042762) | 2.99243668 |
| 109 | immunoglobulin mediated immune response (GO:0016064) | 2.98631175 |
| 110 | cardiac muscle cell action potential (GO:0086001) | 2.98317585 |
| 111 | activation of protein kinase A activity (GO:0034199) | 2.97952811 |
| 112 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96033158 |
| 113 | positive regulation of cation channel activity (GO:2001259) | 2.94677041 |
| 114 | cardiac muscle adaptation (GO:0014887) | 2.94239453 |
| 115 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.94239453 |
| 116 | muscle hypertrophy in response to stress (GO:0003299) | 2.94239453 |
| 117 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.93317449 |
| 118 | response to host defenses (GO:0052200) | 2.93001328 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93001328 |
| 120 | response to host (GO:0075136) | 2.93001328 |
| 121 | heart trabecula formation (GO:0060347) | 2.92969227 |
| 122 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91321379 |
| 123 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91314203 |
| 124 | response to host immune response (GO:0052572) | 2.91314203 |
| 125 | skeletal muscle contraction (GO:0003009) | 2.90448039 |
| 126 | glycogen catabolic process (GO:0005980) | 2.89707711 |
| 127 | skeletal muscle adaptation (GO:0043501) | 2.85735581 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.85186190 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 2.84817711 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.84333518 |
| 131 | tricarboxylic acid metabolic process (GO:0072350) | 2.83927872 |
| 132 | defense response to protozoan (GO:0042832) | 2.83819399 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.82527455 |
| 134 | positive regulation of interferon-alpha production (GO:0032727) | 2.81304527 |
| 135 | adult heart development (GO:0007512) | 2.81042272 |
| 136 | T-helper 1 type immune response (GO:0042088) | 2.80769958 |
| 137 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.80571464 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80383997 |
| 139 | glucan catabolic process (GO:0009251) | 2.79467674 |
| 140 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.79246547 |
| 141 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.78076572 |
| 142 | regulation of sarcomere organization (GO:0060297) | 2.77153346 |
| 143 | striated muscle adaptation (GO:0014888) | 2.75642894 |
| 144 | positive regulation of B cell differentiation (GO:0045579) | 2.74649711 |
| 145 | intracellular lipid transport (GO:0032365) | 2.73747420 |
| 146 | cellular potassium ion homeostasis (GO:0030007) | 2.73462580 |
| 147 | oxygen transport (GO:0015671) | 2.73172471 |
| 148 | B cell homeostasis (GO:0001782) | 2.72760190 |
| 149 | positive regulation of sodium ion transport (GO:0010765) | 2.72084576 |
| 150 | muscle contraction (GO:0006936) | 2.71821772 |
| 151 | cellular response to type I interferon (GO:0071357) | 2.71723903 |
| 152 | type I interferon signaling pathway (GO:0060337) | 2.71723903 |
| 153 | regulation of cation channel activity (GO:2001257) | 2.71424148 |
| 154 | response to protozoan (GO:0001562) | 2.70418712 |
| 155 | regulation of T cell tolerance induction (GO:0002664) | 2.69691188 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.69395786 |
| 157 | regulation of mast cell degranulation (GO:0043304) | 2.68611990 |
| 158 | response to type I interferon (GO:0034340) | 2.68350309 |
| 159 | detection of biotic stimulus (GO:0009595) | 2.67428758 |
| 160 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.67409196 |
| 161 | detection of calcium ion (GO:0005513) | 2.67156293 |
| 162 | leukocyte aggregation (GO:0070486) | 2.66510621 |
| 163 | regulation of tolerance induction (GO:0002643) | 2.64177566 |
| 164 | protein localization to endosome (GO:0036010) | 2.63460025 |
| 165 | quaternary ammonium group transport (GO:0015697) | 2.63103085 |
| 166 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.62909126 |
| 167 | fatty acid beta-oxidation (GO:0006635) | 2.62550533 |
| 168 | regulation of leukocyte degranulation (GO:0043300) | 2.62516706 |
| 169 | myeloid cell activation involved in immune response (GO:0002275) | 2.60916706 |
| 170 | macrophage activation (GO:0042116) | 2.60839057 |
| 171 | tolerance induction (GO:0002507) | 2.59706585 |
| 172 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.59526223 |
| 173 | response to interleukin-15 (GO:0070672) | 2.59150539 |
| 174 | negative thymic T cell selection (GO:0045060) | 2.58335711 |
| 175 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.57596436 |
| 176 | T cell migration (GO:0072678) | 2.57098428 |
| 177 | histone H3-K36 demethylation (GO:0070544) | 2.57060572 |
| 178 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.54941790 |
| 179 | T cell selection (GO:0045058) | 2.53790965 |
| 180 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.53780878 |
| 181 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.53616057 |
| 182 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.53616057 |
| 183 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52433271 |
| 184 | myeloid dendritic cell differentiation (GO:0043011) | 2.51335436 |
| 185 | positive T cell selection (GO:0043368) | 2.48326454 |
| 186 | response to laminar fluid shear stress (GO:0034616) | 2.48107980 |
| 187 | regulation of necrotic cell death (GO:0010939) | 2.47672063 |
| 188 | regulation of B cell differentiation (GO:0045577) | 2.46337736 |
| 189 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.46051475 |
| 190 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.45684896 |
| 191 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45116742 |
| 192 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.44320298 |
| 193 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44233994 |
| 194 | negative T cell selection (GO:0043383) | 2.43973802 |
| 195 | microglial cell activation (GO:0001774) | 2.43636545 |
| 196 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42310191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12045438 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.77328317 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39238132 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03854124 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01539062 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86078191 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83591328 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72429741 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68802633 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61401117 |
| 11 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.59083464 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52549092 |
| 13 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40853356 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38604803 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.34030871 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31760132 |
| 17 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.30123808 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.30123808 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.28303794 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.23688771 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20925866 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.18358562 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.15662681 |
| 24 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13312109 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10311644 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07171604 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05858213 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02173801 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01511229 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01199254 |
| 31 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98392894 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96203736 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94536586 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90638354 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90636117 |
| 36 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88205450 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88140300 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87682722 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86966021 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82637738 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80737176 |
| 42 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.80680002 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79811935 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77201558 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77163627 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74435430 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.72244327 |
| 48 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70462879 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66895315 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66656059 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65318290 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62100618 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60259429 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58261977 |
| 55 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58227774 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56321546 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55217884 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53050734 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50384061 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49007765 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48373766 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46327260 |
| 63 | * MAF_26560356_Chip-Seq_TH2_Human | 1.45203007 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43044930 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42321459 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41441894 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36800538 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.36030621 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34581377 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34049177 |
| 71 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33756346 |
| 72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33043226 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30317270 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28599280 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28519752 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27985982 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27541588 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27372059 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27162694 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25792451 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24437838 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24176917 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23638094 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23510158 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21859024 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21541096 |
| 87 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.19810950 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18192676 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16577230 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16510054 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15841677 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15142180 |
| 93 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14735432 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14596450 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14331375 |
| 96 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13468874 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12766806 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12157136 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11722935 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11293109 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10994855 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10362972 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10350373 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10341341 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10295313 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09157475 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08877850 |
| 108 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05828776 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 1.05452980 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04053390 |
| 111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02397532 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00936562 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00782016 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99983708 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99528880 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99394998 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99006320 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98584129 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97713816 |
| 120 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97622710 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96696044 |
| 122 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96606501 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96507087 |
| 124 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96208917 |
| 125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94812822 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93905447 |
| 127 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93668139 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93642180 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93254150 |
| 130 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.93220715 |
| 131 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92873314 |
| 132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92717792 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92548248 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92507939 |
| 135 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92014918 |
| 136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92014918 |
| 137 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91870205 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91347970 |
| 139 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91113576 |
| 140 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90958960 |
| 141 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90602388 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90303007 |
| 143 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90127968 |
| 144 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90018640 |
| 145 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89640164 |
| 146 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89369660 |
| 147 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88867190 |
| 148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88368404 |
| 149 | * AR_19668381_ChIP-Seq_PC3_Human | 0.88232645 |
| 150 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87959901 |
| 151 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87121595 |
| 152 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86827647 |
| 153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86388239 |
| 154 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86275602 |
| 155 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86148921 |
| 156 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85894727 |
| 157 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85776340 |
| 158 | P68_20966046_ChIP-Seq_HELA_Human | 0.84685693 |
| 159 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84332488 |
| 160 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83596088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.47227664 |
| 2 | MP0003646_muscle_fatigue | 5.34606998 |
| 3 | MP0000751_myopathy | 4.38310855 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.06962086 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.57930174 |
| 6 | MP0005451_abnormal_body_composition | 3.57848015 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.49598042 |
| 8 | MP0000749_muscle_degeneration | 3.19174803 |
| 9 | MP0004130_abnormal_muscle_cell | 3.19026108 |
| 10 | MP0003436_decreased_susceptibility_to | 3.04969968 |
| 11 | MP0005330_cardiomyopathy | 2.92214604 |
| 12 | MP0002822_catalepsy | 2.84799739 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.84143910 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.81495885 |
| 15 | MP0003724_increased_susceptibility_to | 2.39788645 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.38576580 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.33301768 |
| 18 | MP0002972_abnormal_cardiac_muscle | 2.32137291 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.32046007 |
| 20 | MP0002269_muscular_atrophy | 2.31525090 |
| 21 | MP0001800_abnormal_humoral_immune | 2.30056072 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.27308305 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.23045259 |
| 24 | MP0005387_immune_system_phenotype | 2.22340917 |
| 25 | MP0001790_abnormal_immune_system | 2.22340917 |
| 26 | MP0004510_myositis | 2.21243283 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.21035818 |
| 28 | MP0000685_abnormal_immune_system | 2.16936157 |
| 29 | MP0004484_altered_response_of | 2.16738480 |
| 30 | MP0000747_muscle_weakness | 2.15740504 |
| 31 | MP0000750_abnormal_muscle_regeneration | 2.09987097 |
| 32 | MP0002419_abnormal_innate_immunity | 2.08672019 |
| 33 | MP0010630_abnormal_cardiac_muscle | 2.05996646 |
| 34 | MP0008775_abnormal_heart_ventricle | 2.05084739 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 2.02299706 |
| 36 | MP0005385_cardiovascular_system_phenoty | 2.02299706 |
| 37 | MP0009785_altered_susceptibility_to | 1.96472423 |
| 38 | MP0005025_abnormal_response_to | 1.95843035 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.94723707 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.94072130 |
| 41 | MP0002723_abnormal_immune_serum | 1.93785379 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.89537949 |
| 43 | MP0004947_skin_inflammation | 1.86261724 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.83835468 |
| 45 | MP0005671_abnormal_response_to | 1.82686920 |
| 46 | MP0001819_abnormal_immune_cell | 1.81610138 |
| 47 | MP0004233_abnormal_muscle_weight | 1.78917840 |
| 48 | MP0005369_muscle_phenotype | 1.77791433 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.77299646 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.76737159 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.75721130 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.74215981 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.73501656 |
| 54 | MP0006138_congestive_heart_failure | 1.72587095 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.69891997 |
| 56 | MP0004085_abnormal_heartbeat | 1.67371405 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.64749882 |
| 58 | MP0002398_abnormal_bone_marrow | 1.60475569 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.55776701 |
| 60 | MP0002405_respiratory_system_inflammati | 1.55331272 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.54101395 |
| 62 | MP0001853_heart_inflammation | 1.53176768 |
| 63 | MP0002009_preneoplasia | 1.52791752 |
| 64 | MP0000716_abnormal_immune_system | 1.48505201 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.47374301 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.42101055 |
| 67 | MP0008057_abnormal_DNA_replication | 1.39897409 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.39288641 |
| 69 | MP0006082_CNS_inflammation | 1.39183292 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.36691587 |
| 71 | MP0003091_abnormal_cell_migration | 1.36346813 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.35794160 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.33569041 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.31569342 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.31170918 |
| 76 | MP0008260_abnormal_autophagy | 1.31076099 |
| 77 | MP0003300_gastrointestinal_ulcer | 1.30552246 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.30355130 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.29532560 |
| 80 | MP0002722_abnormal_immune_system | 1.26086595 |
| 81 | MP0001845_abnormal_inflammatory_respons | 1.25212042 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.25083288 |
| 83 | MP0000689_abnormal_spleen_morphology | 1.24801368 |
| 84 | MP0003828_pulmonary_edema | 1.24004000 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.22074656 |
| 86 | MP0005670_abnormal_white_adipose | 1.21697580 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.21471640 |
| 88 | MP0000858_altered_metastatic_potential | 1.20682854 |
| 89 | MP0002429_abnormal_blood_cell | 1.19198590 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 1.18274504 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.17789033 |
| 92 | MP0001851_eye_inflammation | 1.15820467 |
| 93 | MP0004381_abnormal_hair_follicle | 1.11455277 |
| 94 | MP0002006_tumorigenesis | 1.11312441 |
| 95 | MP0001873_stomach_inflammation | 1.10602158 |
| 96 | MP0009278_abnormal_bone_marrow | 1.09019351 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 1.08225826 |
| 98 | MP0003635_abnormal_synaptic_transmissio | 1.04430685 |
| 99 | MP0002971_abnormal_brown_adipose | 1.02523860 |
| 100 | MP0003045_fibrosis | 1.02387983 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 1.02084870 |
| 102 | MP0001545_abnormal_hematopoietic_system | 1.02084870 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 1.01746953 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 1.01479439 |
| 105 | MP0000013_abnormal_adipose_tissue | 1.00626907 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.99663996 |
| 107 | MP0008469_abnormal_protein_level | 0.99591892 |
| 108 | MP0008569_lethality_at_weaning | 0.99339458 |
| 109 | MP0005360_urolithiasis | 0.97588725 |
| 110 | MP0004043_abnormal_pH_regulation | 0.95754369 |
| 111 | MP0005310_abnormal_salivary_gland | 0.92131904 |
| 112 | MP0004270_analgesia | 0.91383104 |
| 113 | MP0008004_abnormal_stomach_pH | 0.89876118 |
| 114 | MP0000266_abnormal_heart_morphology | 0.89497756 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.89374980 |
| 116 | MP0005535_abnormal_body_temperature | 0.84266851 |
| 117 | MP0003329_amyloid_beta_deposits | 0.83540948 |
| 118 | MP0003252_abnormal_bile_duct | 0.82273979 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.82183752 |
| 120 | MP0008874_decreased_physiological_sensi | 0.82101314 |
| 121 | MP0003303_peritoneal_inflammation | 0.81699042 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.79728252 |
| 123 | MP0002234_abnormal_pharynx_morphology | 0.79236671 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.77961385 |
| 125 | MP0002063_abnormal_learning/memory/cond | 0.77697769 |
| 126 | MP0005165_increased_susceptibility_to | 0.77057535 |
| 127 | MP0009840_abnormal_foam_cell | 0.75448593 |
| 128 | MP0009745_abnormal_behavioral_response | 0.74631596 |
| 129 | MP0000343_altered_response_to | 0.74625975 |
| 130 | MP0004924_abnormal_behavior | 0.74481249 |
| 131 | MP0005386_behavior/neurological_phenoty | 0.74481249 |
| 132 | MP0005266_abnormal_metabolism | 0.74147289 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.72964962 |
| 134 | MP0000733_abnormal_muscle_development | 0.72778056 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70097858 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.69763073 |
| 137 | MP0002118_abnormal_lipid_homeostasis | 0.68533699 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.68105776 |
| 139 | MP0003075_altered_response_to | 0.66248216 |
| 140 | MP0003633_abnormal_nervous_system | 0.65282538 |
| 141 | MP0002877_abnormal_melanocyte_morpholog | 0.64637103 |
| 142 | MP0010329_abnormal_lipoprotein_level | 0.64278739 |
| 143 | MP0005365_abnormal_bile_salt | 0.63438747 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.63115011 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.61570113 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.60126615 |
| 147 | MP0002064_seizures | 0.60084963 |
| 148 | MP0003191_abnormal_cellular_cholesterol | 0.58858966 |
| 149 | MP0000604_amyloidosis | 0.57650226 |
| 150 | MP0009046_muscle_twitch | 0.57351546 |
| 151 | MP0000609_abnormal_liver_physiology | 0.56796125 |
| 152 | MP0005166_decreased_susceptibility_to | 0.56040309 |
| 153 | MP0005187_abnormal_penis_morphology | 0.55623060 |
| 154 | MP0002128_abnormal_blood_circulation | 0.54963239 |
| 155 | MP0005332_abnormal_amino_acid | 0.53988314 |
| 156 | MP0002139_abnormal_hepatobiliary_system | 0.53720061 |
| 157 | MP0004858_abnormal_nervous_system | 0.53667182 |
| 158 | MP0010368_abnormal_lymphatic_system | 0.53565931 |
| 159 | MP0002166_altered_tumor_susceptibility | 0.53224832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.25924253 |
| 2 | Sudden death (HP:0001699) | 5.91186600 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 5.72365242 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.00722412 |
| 5 | Myoglobinuria (HP:0002913) | 4.88068906 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.82039889 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.67404934 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.60233533 |
| 9 | Bundle branch block (HP:0011710) | 4.57760709 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.35821971 |
| 11 | Atrial fibrillation (HP:0005110) | 4.31467215 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.10337956 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 4.08134591 |
| 14 | Difficulty running (HP:0009046) | 4.04240472 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 3.95715258 |
| 16 | Supraventricular tachycardia (HP:0004755) | 3.86998369 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.85375519 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 3.78529985 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.74537949 |
| 20 | Subaortic stenosis (HP:0001682) | 3.74537949 |
| 21 | Atrioventricular block (HP:0001678) | 3.68155806 |
| 22 | Heart block (HP:0012722) | 3.64452162 |
| 23 | Syncope (HP:0001279) | 3.63709409 |
| 24 | Increased connective tissue (HP:0009025) | 3.63501515 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.62960374 |
| 26 | Dysmetric saccades (HP:0000641) | 3.57468564 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.53519658 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.52900506 |
| 29 | Rhabdomyolysis (HP:0003201) | 3.52450957 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.42574550 |
| 31 | Abnormal atrioventricular conduction (HP:0005150) | 3.40135182 |
| 32 | Lipoatrophy (HP:0100578) | 3.37952530 |
| 33 | Ventricular fibrillation (HP:0001663) | 3.36788239 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.28221579 |
| 35 | Recurrent abscess formation (HP:0002722) | 3.25237192 |
| 36 | Myotonia (HP:0002486) | 3.24108013 |
| 37 | Prolonged QT interval (HP:0001657) | 3.23457545 |
| 38 | Palpitations (HP:0001962) | 3.20253423 |
| 39 | Muscle fiber inclusion bodies (HP:0100299) | 3.10169824 |
| 40 | Abnormality of macrophages (HP:0004311) | 3.09442557 |
| 41 | Muscle stiffness (HP:0003552) | 2.99223388 |
| 42 | Dilated cardiomyopathy (HP:0001644) | 2.96705503 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.95954380 |
| 44 | Difficulty climbing stairs (HP:0003551) | 2.84250496 |
| 45 | Increased IgE level (HP:0003212) | 2.80471856 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.79361180 |
| 47 | Ketoacidosis (HP:0001993) | 2.76167373 |
| 48 | Myositis (HP:0100614) | 2.75892088 |
| 49 | Fatigue (HP:0012378) | 2.74346330 |
| 50 | Orchitis (HP:0100796) | 2.67069657 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64794066 |
| 52 | Recurrent viral infections (HP:0004429) | 2.63112794 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.62399370 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60746929 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.58374487 |
| 56 | Optic neuritis (HP:0100653) | 2.58374487 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.53340205 |
| 58 | Meningitis (HP:0001287) | 2.52901534 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.52832350 |
| 60 | Abnormal EKG (HP:0003115) | 2.49619871 |
| 61 | Chest pain (HP:0100749) | 2.48998753 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.48867946 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.48086284 |
| 64 | Vasculitis (HP:0002633) | 2.47099280 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.45997231 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.38219916 |
| 67 | Stomatitis (HP:0010280) | 2.34944219 |
| 68 | Cellulitis (HP:0100658) | 2.33573467 |
| 69 | Nemaline bodies (HP:0003798) | 2.32153114 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31636362 |
| 71 | Frequent falls (HP:0002359) | 2.31219964 |
| 72 | Resting tremor (HP:0002322) | 2.29725016 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 2.27033912 |
| 74 | Facial diplegia (HP:0001349) | 2.26782672 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.24700721 |
| 76 | Ketosis (HP:0001946) | 2.24674568 |
| 77 | Colitis (HP:0002583) | 2.23755136 |
| 78 | Recurrent skin infections (HP:0001581) | 2.23285621 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23144125 |
| 80 | Slow saccadic eye movements (HP:0000514) | 2.17564904 |
| 81 | Conjunctival hamartoma (HP:0100780) | 2.17399533 |
| 82 | EMG: neuropathic changes (HP:0003445) | 2.17202049 |
| 83 | Hamartoma of the eye (HP:0010568) | 2.17093335 |
| 84 | Lower limb amyotrophy (HP:0007210) | 2.15141554 |
| 85 | Gingivitis (HP:0000230) | 2.14496929 |
| 86 | T lymphocytopenia (HP:0005403) | 2.13504569 |
| 87 | Arterial thrombosis (HP:0004420) | 2.13427301 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.12768086 |
| 89 | Hypoglycemic coma (HP:0001325) | 2.10476862 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09861503 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09861503 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09381018 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.08765162 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00956680 |
| 95 | Obstructive lung disease (HP:0006536) | 2.00956680 |
| 96 | Left ventricular hypertrophy (HP:0001712) | 2.00581990 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.99886249 |
| 98 | Urticaria (HP:0001025) | 1.99194267 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.98689649 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.96623624 |
| 101 | Pheochromocytoma (HP:0002666) | 1.95484389 |
| 102 | Sudden cardiac death (HP:0001645) | 1.95043966 |
| 103 | Abnormality of the endocardium (HP:0004306) | 1.92878362 |
| 104 | Abnormality of T cell number (HP:0011839) | 1.92877359 |
| 105 | Osteomyelitis (HP:0002754) | 1.92292203 |
| 106 | Gout (HP:0001997) | 1.90943345 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.90023929 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 1.88984467 |
| 109 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87816646 |
| 110 | Rapidly progressive (HP:0003678) | 1.87584008 |
| 111 | Hyperammonemia (HP:0001987) | 1.87073763 |
| 112 | Neck muscle weakness (HP:0000467) | 1.86897998 |
| 113 | Progressive external ophthalmoplegia (HP:0000590) | 1.86401459 |
| 114 | Abnormal social behavior (HP:0012433) | 1.85938612 |
| 115 | Impaired social interactions (HP:0000735) | 1.85938612 |
| 116 | Viral hepatitis (HP:0006562) | 1.84806208 |
| 117 | Testicular atrophy (HP:0000029) | 1.84788931 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.83537944 |
| 119 | Hyperkalemia (HP:0002153) | 1.81685483 |
| 120 | Hypoplastic ischia (HP:0003175) | 1.80314006 |
| 121 | Urinary urgency (HP:0000012) | 1.80015931 |
| 122 | Agammaglobulinemia (HP:0004432) | 1.79978735 |
| 123 | Ragged-red muscle fibers (HP:0003200) | 1.79287673 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79249741 |
| 125 | Encephalitis (HP:0002383) | 1.79163645 |
| 126 | Restrictive lung disease (HP:0002091) | 1.78503049 |
| 127 | Epistaxis (HP:0000421) | 1.77521789 |
| 128 | Scapular winging (HP:0003691) | 1.76915399 |
| 129 | Keratoconjunctivitis (HP:0001096) | 1.76603401 |
| 130 | Proximal amyotrophy (HP:0007126) | 1.75908434 |
| 131 | Distal arthrogryposis (HP:0005684) | 1.74533370 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.74400937 |
| 133 | Central scotoma (HP:0000603) | 1.74333273 |
| 134 | Subacute progressive viral hepatitis (HP:0006572) | 1.73995334 |
| 135 | Polycythemia (HP:0001901) | 1.73816993 |
| 136 | Cerebral aneurysm (HP:0004944) | 1.73714575 |
| 137 | Amyloidosis (HP:0011034) | 1.73574957 |
| 138 | Focal motor seizures (HP:0011153) | 1.72851340 |
| 139 | Toxemia of pregnancy (HP:0100603) | 1.72331161 |
| 140 | Progressive muscle weakness (HP:0003323) | 1.71956988 |
| 141 | Bulbar palsy (HP:0001283) | 1.71905435 |
| 142 | Cholelithiasis (HP:0001081) | 1.71200780 |
| 143 | Ulnar deviation of the wrist (HP:0003049) | 1.70850482 |
| 144 | Verrucae (HP:0200043) | 1.70800477 |
| 145 | Papilloma (HP:0012740) | 1.70800477 |
| 146 | Hyperglycemia (HP:0003074) | 1.70650869 |
| 147 | Abnormality of the Achilles tendon (HP:0005109) | 1.70360763 |
| 148 | Myopathic facies (HP:0002058) | 1.69898801 |
| 149 | Myokymia (HP:0002411) | 1.67103258 |
| 150 | Foot dorsiflexor weakness (HP:0009027) | 1.65847255 |
| 151 | Lymphangioma (HP:0100764) | 1.65821120 |
| 152 | Broad metatarsal (HP:0001783) | 1.64540983 |
| 153 | Round ear (HP:0100830) | 1.64413345 |
| 154 | Abnormality of the foot musculature (HP:0001436) | 1.62700075 |
| 155 | Congestive heart failure (HP:0001635) | 1.61923078 |
| 156 | Athetosis (HP:0002305) | 1.61865118 |
| 157 | Hyperglycinuria (HP:0003108) | 1.61699381 |
| 158 | Palmoplantar keratoderma (HP:0000982) | 1.61234387 |
| 159 | Hypoalphalipoproteinemia (HP:0003233) | 1.61205993 |
| 160 | Poor eye contact (HP:0000817) | 1.61043435 |
| 161 | Neuroendocrine neoplasm (HP:0100634) | 1.60355820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.39804128 |
| 2 | TTN | 4.37555573 |
| 3 | TRIB3 | 3.81376765 |
| 4 | PKN2 | 3.19846250 |
| 5 | PHKG2 | 2.82961659 |
| 6 | PHKG1 | 2.82961659 |
| 7 | PDK4 | 2.74013203 |
| 8 | PDK3 | 2.74013203 |
| 9 | LMTK2 | 2.73827929 |
| 10 | OBSCN | 2.70556866 |
| 11 | MAP3K14 | 2.60509323 |
| 12 | DMPK | 2.52520017 |
| 13 | NEK1 | 2.16745632 |
| 14 | CDK12 | 2.05322087 |
| 15 | IRAK4 | 1.90477908 |
| 16 | BLK | 1.85458786 |
| 17 | PINK1 | 1.78227761 |
| 18 | KSR2 | 1.73724534 |
| 19 | RIPK1 | 1.73264385 |
| 20 | PRKD3 | 1.71218171 |
| 21 | ZAP70 | 1.65921130 |
| 22 | TAOK1 | 1.65188295 |
| 23 | PDK2 | 1.62106932 |
| 24 | CSK | 1.60538264 |
| 25 | EPHA4 | 1.57895271 |
| 26 | MAP3K7 | 1.56124730 |
| 27 | TBK1 | 1.51659714 |
| 28 | STK38 | 1.51442903 |
| 29 | TAOK2 | 1.51082518 |
| 30 | LATS1 | 1.48949447 |
| 31 | IRAK3 | 1.46858570 |
| 32 | IKBKE | 1.40234438 |
| 33 | MAP3K9 | 1.39049019 |
| 34 | TRPM7 | 1.35261275 |
| 35 | BMPR2 | 1.34084765 |
| 36 | SIK3 | 1.33337987 |
| 37 | PIK3CG | 1.24919551 |
| 38 | BCKDK | 1.20957535 |
| 39 | CAMKK1 | 1.18896331 |
| 40 | PRKCH | 1.18564053 |
| 41 | MAP2K4 | 1.15878459 |
| 42 | EEF2K | 1.12999438 |
| 43 | PAK6 | 1.10433153 |
| 44 | BTK | 1.08167013 |
| 45 | BRD4 | 1.07348389 |
| 46 | SGK3 | 1.07108305 |
| 47 | MAP2K3 | 1.06997919 |
| 48 | RET | 1.06407768 |
| 49 | PDK1 | 1.06344543 |
| 50 | MAP3K4 | 1.05204807 |
| 51 | SYK | 1.04838530 |
| 52 | MOS | 1.04351119 |
| 53 | IRAK1 | 1.03607479 |
| 54 | IRAK2 | 1.02732986 |
| 55 | PDGFRA | 1.00716658 |
| 56 | MYLK | 0.98942541 |
| 57 | FGFR4 | 0.97259771 |
| 58 | NTRK3 | 0.95357272 |
| 59 | PIK3CA | 0.95305566 |
| 60 | IKBKB | 0.93611584 |
| 61 | MARK3 | 0.93505070 |
| 62 | FGFR3 | 0.93432750 |
| 63 | MAP4K1 | 0.92385625 |
| 64 | MAPK7 | 0.92201928 |
| 65 | JAK1 | 0.92148252 |
| 66 | DAPK2 | 0.90090134 |
| 67 | PDPK1 | 0.89432703 |
| 68 | LATS2 | 0.87828895 |
| 69 | STK10 | 0.87469293 |
| 70 | PTK6 | 0.86057384 |
| 71 | STK24 | 0.85968874 |
| 72 | HIPK2 | 0.84997937 |
| 73 | SMG1 | 0.83892175 |
| 74 | TXK | 0.83198374 |
| 75 | MATK | 0.83058296 |
| 76 | PRKD1 | 0.82921507 |
| 77 | PAK3 | 0.81961201 |
| 78 | CDK6 | 0.81846256 |
| 79 | FES | 0.80566977 |
| 80 | PRKAA1 | 0.79190846 |
| 81 | WNK1 | 0.78866945 |
| 82 | CSF1R | 0.77113533 |
| 83 | MAPK12 | 0.77069981 |
| 84 | MAP3K5 | 0.75457854 |
| 85 | YES1 | 0.75017808 |
| 86 | CAMK1G | 0.73549893 |
| 87 | ERN1 | 0.73000934 |
| 88 | FGR | 0.72868744 |
| 89 | PRKAA2 | 0.72428292 |
| 90 | MAP3K10 | 0.71682924 |
| 91 | TYRO3 | 0.70780515 |
| 92 | CAMK1D | 0.68110446 |
| 93 | ALK | 0.66873614 |
| 94 | CAMK4 | 0.66145010 |
| 95 | CHUK | 0.65731575 |
| 96 | TGFBR2 | 0.65187612 |
| 97 | LRRK2 | 0.64987781 |
| 98 | SGK2 | 0.64835015 |
| 99 | CDK4 | 0.63842162 |
| 100 | MAPK11 | 0.63674786 |
| 101 | MAP3K11 | 0.63547915 |
| 102 | KIT | 0.63512526 |
| 103 | TYK2 | 0.62054582 |
| 104 | LYN | 0.61772540 |
| 105 | LCK | 0.61648408 |
| 106 | JAK2 | 0.61627031 |
| 107 | PDGFRB | 0.61014172 |
| 108 | STK11 | 0.59650964 |
| 109 | NLK | 0.59229307 |
| 110 | JAK3 | 0.58825312 |
| 111 | MAP3K1 | 0.58764672 |
| 112 | MAP3K2 | 0.58683498 |
| 113 | RAF1 | 0.58571675 |
| 114 | CDC42BPA | 0.58226085 |
| 115 | KSR1 | 0.57541514 |
| 116 | SIK2 | 0.57015490 |
| 117 | MAP3K13 | 0.55295819 |
| 118 | MUSK | 0.55277185 |
| 119 | ICK | 0.53909249 |
| 120 | TEC | 0.52850731 |
| 121 | RIPK4 | 0.51828678 |
| 122 | CAMKK2 | 0.51533862 |
| 123 | SGK1 | 0.51346982 |
| 124 | EPHB1 | 0.51093455 |
| 125 | PTK2B | 0.50756084 |
| 126 | FLT3 | 0.50428157 |
| 127 | SIK1 | 0.50237819 |
| 128 | MINK1 | 0.49690297 |
| 129 | ROCK1 | 0.48964021 |
| 130 | MAPKAPK3 | 0.46393742 |
| 131 | ILK | 0.46208817 |
| 132 | GRK7 | 0.45404938 |
| 133 | PIM1 | 0.44501220 |
| 134 | ITK | 0.43683992 |
| 135 | CAMK1 | 0.42346127 |
| 136 | MTOR | 0.41931573 |
| 137 | CAMK2D | 0.41706832 |
| 138 | NTRK1 | 0.41553272 |
| 139 | MAPK4 | 0.39876523 |
| 140 | RPS6KC1 | 0.39466870 |
| 141 | RPS6KL1 | 0.39466870 |
| 142 | RPS6KA3 | 0.38491485 |
| 143 | MAP3K3 | 0.38094369 |
| 144 | MAP3K6 | 0.37037140 |
| 145 | PRKACG | 0.36631807 |
| 146 | GRK6 | 0.36277903 |
| 147 | WNK4 | 0.35476704 |
| 148 | STK38L | 0.35318020 |
| 149 | HCK | 0.33866925 |
| 150 | NEK9 | 0.33851475 |
| 151 | MARK2 | 0.33692759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.01089680 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.57182483 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.13916814 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43461577 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.36691149 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.24395742 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14787072 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.14457971 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07659667 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04208351 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.96993027 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.95743654 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.94512682 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83802621 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73840260 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72792453 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70675547 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69340392 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.69043424 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65441276 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.63149299 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61346237 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.60721434 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60699751 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.60276485 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58656206 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55603332 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54586206 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52624773 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46965318 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.45968990 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43994677 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43834281 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43350920 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43327477 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42929615 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.39391359 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.37133116 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36209217 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35556822 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33718857 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33654189 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.32353332 |
| 44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30177476 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28684406 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28485166 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27747487 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 1.26981814 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.26801063 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26498421 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.23837304 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21852256 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20333686 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19807945 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.19577032 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17737885 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17112024 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16899954 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16787860 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16024674 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15897265 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15831574 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14452789 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12244587 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 1.11374760 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09567800 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08445696 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08349730 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05174412 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04569066 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01985121 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01869593 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01712350 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00596268 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 1.00049931 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98475344 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97400474 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96737344 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.94631102 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94122890 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93153435 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92126294 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.91313197 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90802800 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.90019297 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.87946190 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86338144 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85259568 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84358819 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83996342 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.83882161 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83880398 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83494031 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82091875 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.81451440 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81088145 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80835288 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.80501421 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80441345 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80216217 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80056007 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78791958 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78283177 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77651027 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77600386 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77475149 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76030304 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75231132 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75000785 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.72953340 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72550137 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71775228 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71084322 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70772958 |
| 115 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70184531 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.70168735 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69968235 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69237415 |
| 119 | Morphine addiction_Homo sapiens_hsa05032 | 0.69187874 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66841374 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.66188352 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66058231 |
| 123 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65596567 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65371106 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62919621 |
| 126 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61724280 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61607960 |
| 128 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60069773 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58884743 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.58601167 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.57991553 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56251513 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | 0.55204636 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54548946 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52914123 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52544753 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51977490 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49583170 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47470346 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47132786 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47083030 |
| 142 | Gap junction_Homo sapiens_hsa04540 | 0.46385428 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46172581 |
| 144 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45979534 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44067573 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43503639 |
| 147 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42061609 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40985602 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40128722 |
| 150 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39889968 |
| 151 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39501005 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.39441578 |
| 153 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39331056 |
| 154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38104077 |
| 155 | Adherens junction_Homo sapiens_hsa04520 | 0.37925290 |
| 156 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37653839 |
| 157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37308062 |
| 158 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35758530 |

